share_log

MyndTec Announces Investor Relations Agreement with Venture North Capital

MyndTec Announces Investor Relations Agreement with Venture North Capital

MyndTec宣佈與Venture North Capital達成投資者關係協議
newsfile ·  2022/05/04 08:52

Mississauga, Ontario--(Newsfile Corp. - May 3, 2022) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), an emerging leader in neurological rehabilitation, is pleased to announce that it has entered into a consulting agreement (the "Consulting Agreement") with Venture North Capital Inc. ("Venture North") to provide strategic marketing, investor relations and capital markets communications services to the Company in compliance with the policies and guidelines of the Canadian Securities Exchange (the "CSE"). Venture North will arrange and attend meetings with professional investors, maintain ongoing contact and broaden relationships with the professional investment community on MyndTec's behalf.

安大略省密西索加-(Newsfile Corp.-2022年5月3日)-MyndTec Inc.(CSE:MYTC)(“聯合科技公司“或”公司)很高興地宣佈,它已與北方風險投資公司(“北方風險投資”)簽訂了一項諮詢協議(“諮詢協議”),根據加拿大證券交易所(CSE)的政策和指導方針,為公司提供戰略營銷、投資者關係和資本市場溝通服務。北方風險投資公司將代表MyndTec安排和出席與專業投資者的會議,保持持續聯繫,並擴大與專業投資界的關係。

The Consulting Agreement is effective May 3, 2022 for an initial 3-month period ending July 31, 2022, after which it will continue in effect on a monthly basis until terminated upon 30 days written notice given by either the Company or Venture North. Pursuant to the Consulting Agreement, the Company will pay Venture North $6,000 plus applicable taxes per month and grant Venture North 200,000 stock options (the "Options") of the Company. Each Option is exercisable into one common share (each, a "Share") of the Company at an exercise price of $0.95 per Share and the Options will vest at a rate of 25% per quarter. All vested Options shall be eligible for exercise for a period expiring on the 10th anniversary of the grant date provided that all unvested Options will terminate and expire on the date that the Consulting Agreement is terminated.

諮詢協議於2022年5月3日生效,最初為期3個月,截至2022年7月31日,之後將繼續按月生效,直至本公司或Venture North發出30天書面通知後終止。根據諮詢協議,本公司將每月向Venture North支付6,000美元外加適用税金,並授予Venture North 200,000份本公司股票期權(“期權”)。每項購股權可行使為一股本公司普通股(每股,“股份”),行使價為每股0.95美元,認購權將以每季度25%的速度授予。所有既得期權均有資格在10月10日到期的期限內行使。這是如果所有未授出的期權將在諮詢協議終止之日終止和失效,則為授予日的週年紀念日。

About MyndTec

關於MyndTec

MyndTec is a Canadian medical technology company dedicated to the development and commercialization of innovative products that improve function, maximize independence and enhance the quality of life for individuals who have suffered injury to the central nervous system as a result of stroke, spinal cord injury and certain traumatic brain injuries. The Company develops non-invasive neurological and nervous system electrical stimulation therapeutics for the treatment of neurological diseases and injury specifically targeted to markets with large, growing and global patient populations. The Company's flagship product MyndMove™ is a non-invasive functional electrical stimulation-based intervention. MyndMove™ uses neuroplasticity mechanisms to stimulate development of new neural efferent and afferent pathways allowing patients to re-establish voluntary movement and improve independence in their activities of daily living. The MyndMove™ system offers trained therapists the ability to assist individuals affected with paralysis to improve voluntary control of their limbs. The MyndMove™ therapy system offers a broad spectrum of sophisticated functional electrical stimulation software protocols which therapists customize to patient needs to enable meaningful controlled movements via proprietary stimulation technology.

MyndTec是一家加拿大醫療技術公司,致力於創新產品的開發和商業化,這些產品可以改善功能,最大限度地提高獨立性,並提高因中風、脊髓損傷和某些創傷性腦損傷而遭受中樞神經系統損傷的個人的生活質量。該公司開發非侵入性神經和神經系統電刺激療法,用於治療神經系統疾病和損傷,專門針對擁有大量、不斷增長的全球患者羣體的市場。該公司的旗艦產品MyndMove™是一種基於電刺激的非侵入性功能性幹預產品。MyndMove™使用神經可塑性機制來刺激新的神經傳出和傳入路徑的發展,使患者能夠重新建立自願運動,並提高他們日常生活活動的獨立性。MyndMove™系統為訓練有素的治療師提供了幫助癱瘓患者改善對其肢體的自願控制的能力。MyndMove™治療系統提供了一系列複雜的功能性電刺激軟件協議,治療師根據患者的需要進行定製,通過專有的刺激技術實現有意義的可控運動。

For more information visit

有關更多信息,請訪問

Contact Information

聯繫信息

Craig Leon
MyndTec Inc. | Chief Executive Officer
investor.relations@myndtec.com
Tel: (416) 569-0430

克雷格·利昂
MyndTec Inc.|首席執行官
郵箱:investor.relationship@myndtec.com
電話:(416)569-0430

Bill Mitoulas
Venture North Capital Inc. | Principal
billm@venturenorthcapital.com
Tel: (416) 479-9547

比爾·米圖拉斯
Venture North Capital Inc.|負責人
郵箱:billm@venturenorecapal.com
電話:(416)479-9547

Cautionary Note Regarding Forward-Looking Statements

有關前瞻性陳述的注意事項

This news release contains forward-looking statements that constitute "forward-looking information" within the meaning of applicable Canadian securities laws (collectively, "forward-looking statements"). All statements in this news release that are not historical facts are forward-looking statements, including, but not limited to, all statements regarding: events, performance or results of operations that the Company believes, expects or anticipates will or may occur in the future; the duration of the Consulting Agreement, the services provided under the Consulting Agreement; and the consideration paid pursuant to the Consulting Agreement. Forward-looking statements are typically, but not always, identified by words such as: "believes", "expects", "aim", "anticipates", "intends", "estimates", "plans", "may", "should", "could", "continue", "would", "will", "potential", "scheduled", "goal", "target", or variations of such words and phrases and similar expressions, which, by their nature, refer to future events or results that may, could, would, might or will occur or be taken or achieved.

本新聞稿包含前瞻性陳述,構成適用加拿大證券法的“前瞻性信息”(統稱為“前瞻性陳述“)。本新聞稿中所有非歷史事實的陳述均為前瞻性陳述,包括但不限於以下所有陳述:公司相信、預期或預期未來將或可能發生的事件、業績或經營結果;諮詢協議的期限;根據諮詢協議提供的服務;以及根據諮詢協議支付的對價。前瞻性陳述通常但並非總是由下列詞語來標識:“相信”、“預期”、“目標”、“預期”、“打算”、“估計”、“計劃”、“可能”、“應該”、“可能”、“繼續”、“將”、“將”、“可能”、“預定”、“目標”、“目標”或此類詞語和短語的變體以及類似的表述,這些詞語和短語的本質是指可能、可能、將、可能或將會發生、被採取或實現。

Forward-looking statements are necessarily based on a number of estimates and assumptions that include, but are not limited to: expected future development; general economic conditions; the ability of the Company to execute on its business objectives; and other estimates and assumptions described in the Company's Listing Statement dated February 18, 2022 (the "Listing Statement"), a copy of which is available under the Company's profile on SEDAR at . Forward-looking statements are inherently subject to a number of significant risks and uncertainties that could cause the actual results or events to differ materially from those described in the forward-looking statements. Important risks and uncertainties that could cause actual results or events to differ materially from expectations include, but are not limited to: the Company's ability to continue as a going concern, the Company's research, development and commercialization of its products could be stopped or delayed if any third party fails to provide sufficient quantities of products or components, or fails to do so at acceptable quality levels or prices, or fails to maintain or achieve satisfactory regulatory compliance; the Company expects to incur significant ongoing costs and obligations relating to its investment in infrastructure, growth, research and development, regulatory compliance and operations; and other risks and uncertainties described in the Listing Statement. The Company has attempted to identify important factors that could cause actual results, performance or achievements to vary from those expectations expressed or implied by the forward-looking statements, however, there may be other factors that cause results, performance or achievements not to be as expected and that could cause actual results, performance or achievements to differ materially from current expectations. These forward-looking statements are only current as of the date of this news release. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, such statements involve risks and uncertainties and the Company provides no assurance that they will prove to be correct. Readers should not place undue reliance on such forward-looking statements. The Company does not undertake any obligation to update forward-looking statements contained herein, other than as required by applicable law. All forward-looking statements are qualified in their entirety by this cautionary statement.

前瞻性陳述必須基於若干估計和假設,這些估計和假設包括但不限於:預期的未來發展;總體經濟狀況;公司執行其業務目標的能力;以及公司於2022年2月18日的上市聲明(“上市聲明”)中描述的其他估計和假設。上市聲明“),其副本可在SEDAR上的公司簡介下查閲,網址為:。前瞻性陳述固有地受到許多重大風險和不確定因素的影響,這些風險和不確定因素可能導致實際結果或事件與前瞻性陳述中所描述的大不相同。可能導致實際結果或事件與預期大不相同的重要風險和不確定因素包括但不限於:如果任何第三方未能提供足夠數量的產品或部件,或未能以可接受的質量水平或價格這樣做,或未能維持或實現令人滿意的監管合規,公司作為持續經營企業繼續經營的能力,公司的產品研究、開發和商業化可能會停止或推遲;公司預計將產生與其基礎設施投資、增長、研發、監管合規和運營相關的重大持續成本和義務;以及上市聲明中描述的其他風險和不確定性。公司試圖確定可能導致實際結果、業績或成就與前瞻性陳述明示或暗示的預期不同的重要因素,然而,可能存在其他因素導致結果、業績或成就與預期不符,可能導致實際結果、業績或成就與當前預期大不相同。這些前瞻性陳述僅是截至本新聞稿發佈之日的最新情況。儘管本公司認為該等前瞻性陳述所反映的預期是合理的, 此類陳述涉及風險和不確定因素,公司不能保證這些陳述將被證明是正確的。讀者不應過分依賴這種前瞻性陳述。除適用法律要求外,公司不承擔更新本文中包含的前瞻性陳述的任何義務。所有前瞻性陳述均受本警告性聲明的限制。

The CSE has in no way passed upon the merits of the business of the Company and has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.

CSE絕不傳遞本公司業務的優點,既不批准或不批准本新聞稿的內容,也不對本新聞稿的充分性或準確性承擔任何責任。

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.

不得分發給美國新聞通訊社或在美國境內傳播。

To view the source version of this press release, please visit

要查看本新聞稿的源版本,請訪問

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論